Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A double-blind, placebo controlled trial of risperidone for the treatment of anorexia nervosa.

Trial Profile

A double-blind, placebo controlled trial of risperidone for the treatment of anorexia nervosa.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Feb 2016

At a glance

  • Drugs Risperidone (Primary)
  • Indications Anorexia nervosa
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Sep 2011 Status changed from active, no longer recruiting to completed, based on publication of results.
    • 01 Sep 2011 Results published in the Journal of the American Academy of Child and Adolescent Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top